1. Home
  2. QTRX vs BDTX Comparison

QTRX vs BDTX Comparison

Compare QTRX & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanterix Corporation

QTRX

Quanterix Corporation

HOLD

Current Price

$3.71

Market Cap

160.0M

Sector

Industrials

ML Signal

HOLD

Logo Black Diamond Therapeutics Inc.

BDTX

Black Diamond Therapeutics Inc.

HOLD

Current Price

$1.79

Market Cap

171.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QTRX
BDTX
Founded
2007
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.0M
171.9M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
QTRX
BDTX
Price
$3.71
$1.79
Analyst Decision
Hold
Strong Buy
Analyst Count
2
7
Target Price
$6.00
$9.67
AVG Volume (30 Days)
747.3K
1.6M
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
130.71
EPS
N/A
N/A
Revenue
$37,632,000.00
N/A
Revenue This Year
$25.49
N/A
Revenue Next Year
$10.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
64.52
N/A
52 Week Low
$2.40
$1.60
52 Week High
$8.77
$4.94

Technical Indicators

Market Signals
Indicator
QTRX
BDTX
Relative Strength Index (RSI) 47.36 42.31
Support Level $3.30 $1.76
Resistance Level $3.81 $2.26
Average True Range (ATR) 0.32 0.11
MACD -0.06 0.01
Stochastic Oscillator 9.37 6.17

Price Performance

Historical Comparison
QTRX
BDTX

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.

Share on Social Networks: